Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001317757-10-000017)

Filing Details

Accession Number:: 0001317757-10-000017
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-06-01 13:00:00
Reporting Period:: 2010-05-28

Filing Date:: 2010-06-01
Accepted Time:: 2010-06-01 16:00:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
792977	Amag Pharmaceuticals Inc.	AMAG	In Vitro & In Vivo Diagnostic Substances (2835)	042742593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1296999	David Arkowitz	C/O Amag Pharmaceuticals, Inc. 100 Hayden Avenue Lexington MA 02421	Evp, Cfo And Cbo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-05-28	658	$27.06	1,886	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These shares were acquired by the reporting person pursuant to the Company's 2010 Employee Stock Purchase Plan. The purchase price for the shares was 85% of the closing price of the Company's common stock on May 28, 2010.